[1. Zhou Y, Dai W, Lin C, Wang F, He L, Shen M, Chen P, Wang C, Lu J, Xu L, XuX,Guo C. Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm. 2013;2013:706156.10.1155/2013/706156380645524198446]Search in Google Scholar
[2. Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. ClinExpImmunol. 1982;50:17-24.]Search in Google Scholar
[3. Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M. Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells. 2011 (1):5-10.10.1002/stem.556305941021280154]Search in Google Scholar
[4. Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74:2345-2360.10.1007/s00018-017-2473-528214990]Search in Google Scholar
[5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC,Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-9.10.1038/nature0087012077603]Search in Google Scholar
[6. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111:1327-33.10.1182/blood-2007-02-07499717951526]Search in Google Scholar
[7. Nikolic A, SimovicMarkovic B, Gazdic M, Randall Harrell C, FellabaumC,Jovicic N, Djonov V, Arsenijevic N, L Lukic M, Stojkovic M, VolarevicV.Intraperito-neal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Biomed Pharmacother. 2018;100:426-432.10.1016/j.biopha.2018.02.06029471245]Search in Google Scholar
[8. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005;175:1540-50.10.4049/jimmunol.175.3.154016034092]Search in Google Scholar
[9. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90:196-203.10.1172/JCI1158364430811634608]Search in Google Scholar
[10. Volarevic V, Misirkic M, Vucicevic L, Paunovic V, SimovicMarkovicB,Stojanovic M, Milovanovic M, Jakovljevic V, Micic D, Arsenijevic N, Trajkovic V, Lukic ML. Metformin aggravates immune-mediated liver injury in mice. Arch Toxicol. 2015;89:437-50.10.1007/s00204-014-1263-124770553]Search in Google Scholar
[11. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, MitrovicS,Pejnovic N, Arsenijevic N, Lukic ML. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol. 2012;56:26-33.10.1016/j.jhep.2011.03.02221703183]Search in Google Scholar
[12. Gazdic M, SimovicMarkovic B, Vucicevic L, Nikolic T, Djonov V, ArsenijevicN,Trajkovic V, Lukic ML, Volarevic V. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. J Tissue EngRegen Med. 2018;12:e1173-e1185.10.1002/term.245228488390]Search in Google Scholar
[13. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005;175:1540-50.10.4049/jimmunol.175.3.154016034092]Search in Google Scholar
[14. Milosavljevic N, Gazdic M, SimovicMarkovic B, Arsenijevic A, NurkovicJ,Dolicanin Z, Djonov V, Lukic ML, Volarevic V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23:1040-1050.10.1002/lt.2478428481005]Search in Google Scholar
[15. Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR,Fellabaum C, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018;24:687-702.10.1002/lt.2504929500914]Search in Google Scholar
[16. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology. 2012;55:1954-64.10.1002/hep.2554222213244]Search in Google Scholar
[17. Volarevic V, Markovic BS, Bojic S, Stojanovic M, Nilsson U, Leffler H, Besra GS, Arsenijevic N, Paunovic V, Trajkovic V, Lukic ML. Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury. Eur J Immunol. 2015;45:531-43.10.1002/eji.20144484925359399]Search in Google Scholar
[18. Linero I, Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One. 2014;9:e107001.10.1371/journal.pone.0107001415784425198551]Search in Google Scholar
[19. Yang SH, Park MJ, Yoon IH, Kim SY, Hong SH, Shin JY, Nam HY, Kim YH, Kim B, Park CG. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. ExpMol Med. 2009;41:315-24.10.3858/emm.2009.41.5.035270198019307751]Search in Google Scholar
[20. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-22.10.1182/blood-2004-04-155915494428]Search in Google Scholar
[21. Milosavljevic N, Gazdic M, SimovicMarkovic B, Arsenijevic A, NurkovicJ,Dolicanin Z, Jovicic N, Jeftic I, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Mes-enchymal stem cells attenuate liver fibrosis by suppressing Th17 cells – an experimental study. Transpl Int. 2018;31:102-11510.1111/tri.1302328805262]Search in Google Scholar
[22. Lim JY, Im KI, Lee ES, Kim N, Nam YS, Jeon YW, Cho SG. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6:26851.10.1038/srep26851488799827246365]Search in Google Scholar
[23. Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells. 2014;32:2818-23.10.1002/stem.181825154380]Search in Google Scholar
[24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61.10.1126/science.107949012522256]Search in Google Scholar
[25. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-42.10.1038/396149338786]Search in Google Scholar
[26. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nature medicine. 2013; 19:739–46.10.1038/nm.317923624599]Search in Google Scholar
[27. Ahangarani RR, Janssens W, VanderElst L, Carlier V, VandenDriessche T, Chuah M, Weynand B, Vanoirbeek JA, Jacquemin M, Saint-Remy JM. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness. J Immunol. 2009;183:8232-43.10.4049/jimmunol.090177720007587]Search in Google Scholar
[28. Xu L, Yin W, Sun R, Wei H, Tian Z. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. ProcNatlAcadSci U S A. 2013;110:16993-8.10.1073/pnas.1306437110380106224089450]Search in Google Scholar
[29. Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, Gorin NC, Fouillard L. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol. 2008;253:16-22.10.1016/j.cellimm.2008.06.00218639869]Search in Google Scholar
[30. Carpentier A, Conti F, Stenard F, Aoudjehane L, Miroux C, Podevin P, Morales O, Chouzenoux S, Scatton O, Groux H, Auriault C, Calmus Y, Pancre V, DelhemN. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant. 2009;9:2102-12.10.1111/j.1600-6143.2009.02743.x19624566]Search in Google Scholar
[31. Wildbaum G, Netzer N, Karin N. Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest. 2002;110:701-1010.1172/JCI0215176]Search in Google Scholar
[32. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22:633-42.10.1016/j.immuni.2005.03.01315894280]Search in Google Scholar
[33. Eleftheriadis T, Pissas G, Karioti A, Antoniadi G, Liakopoulos V, Dafopoulou K, Pournaras S, Koukoulis G, Stefanidis I. The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes. Immunol Invest. 2012;41:507-20.10.3109/08820139.2012.68224422594922]Search in Google Scholar